Affiliation: Cancer Registry of Norway
- Proportion cured models applied to 23 cancer sites in NorwayMilada Cvancarova
Department of Registration, Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo, Norway National Resource Center for Late Effects, Department of Oncology, Oslo University Hospital, Norway
Int J Cancer 132:1700-10. 2013..The absolute estimates of the cure proportion are speculative and should not be calculated where cure is not medically anticipated...
- Pregnancy after adolescent and adult cancer: a population-based matched cohort studyHanne Stensheim
Department of Clinical and Registry based Research, Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo, Norway
Int J Cancer 129:1225-36. 2011..9 (95% CI 0.7-1.0)]. In summary, fertility-preserving attempts have succeeded in patients with ovarian or testicular cancer and in males with Hodgkin lymphoma. Male survivors initiated pregnancies in a higher degree than female survivors...
- Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN StudyMarte Lie Høivik
Division of Medicine, Department of Gastroenterology, Oslo University Hospital, Aker, P O Box 4959 Nydalen, 0424 Oslo, Norway
Gut 62:368-75. 2013....
- Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormonesAndreas Stensvold
Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
Prostate 72:668-76. 2012..We compared these methods to examine changes of sexual, urinary, and bowel functions after robot-assisted prostatectomy (RALP) and conformal external beam radiotherapy (EBRT) in patients without androgen deprivation therapy (ADT)...
- Prognostic variables in oligodendroglial tumors: a single-institution study of 95 casesDavid Scheie
Department of Pathology, Oslo University Hospital, Rikshospitalet, P O Box 4950 Nydalen, 0424 Oslo, Norway
Neuro Oncol 13:1225-33. 2011..The study suggests that solitary 19q loss is a negative prognostic variable and that 1p/19q loss is associated with prolonged survival also in oligodendroglial tumors without classic histology...
- Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancerMette Sprauten
Norwegian Radium Hospital Oslo University Hospital, Oslo, Norway
J Clin Oncol 30:300-7. 2012..Cisplatin-induced neurotoxicity and ototoxicity (NTX) are important adverse effects after chemotherapy for testicular cancer (TC). Although serum platinum is measurable years after therapy, its impact on NTX has not been evaluated...